Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before having weight loss surgery, suggesting that a surgery first strategy… read more.
A new study by researchers at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, in collaboration with researchers at Harvard T.H. Chan School of Public… read more.
Young people diagnosed with severe obesity who had weight-loss surgery at age 19 or younger have achieved sustained weight loss 10 years later, researchers reported on Oct. 30,… read more.
Systematic reviews* of medical literature between 2020 to 2024 show bariatric surgery, also known as metabolic or weight-loss surgery, produces the greatest and most sustained weight loss compared… read more.
People with type 2 diabetes who underwent bariatric surgery achieved better long-term blood glucose control compared to people who received medical management plus lifestyle interventions, according to a… read more.
Metabolic or bariatric surgery results in superior glycemic control, less medication usage and high rates of remission of Type 2 diabetes than medical or lifestyle intervention in patients… read more.
Bariatric surgery treats advanced non-alcoholic fatty liver disease (NASH) significantly more effectively than drug or lifestyle intervention, researchers reported on April 20, 2023 in The Lancet. Professor Francesco… read more.
Being able to take a quick walk to a nearby food retail store may be a significant factor in long-term weight loss after bariatric surgery, new research suggests…. read more.
Bariatric surgery appears to provide durable improvement in urinary incontinence, researchers reported on Dec. 9, 2022 in JAMA Network Open. “Specifically, over half of women and men with… read more.
New research involving adults diagnosed with nonalcoholic fatty liver disease (NAFLD) and morbid obesity (body mass index > 40) indicates that subjects who had bariatric surgery achieved a… read more.
Two of the world’s leading authorities on bariatric and metabolic surgery have issued new evidence-based clinical guidelines that among a slew of recommendations expand patient eligibility for weight-loss… read more.
The risk of type 2 diabetes (T2D) is more than halved by weekly injections of new obesity drug semaglutide, according to new research being presented at the annual… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
